AIDS: Reports of metabolic disorders, such as diabetes mellitus and hyperlipidemia,
occurring during treatment with protease inhibitor (PI) regimens are prompting patients and …

Antiretroviral therapy has revolutionized the care of people with human immunodeficiency
virus (HIV) by reducing morbidity and mortality from acquired immunodeficiency syndrome …

Inflammation, cholesterol abnormalities, and lipodystrophy caused by both HIV infection and
antiretroviral therapy may pose aging HIV-infected patients at a higher risk of comorbidities …

Abstract Purpose of Review The aim of this review is to summarize knowledge of the
prevalence, relevant physiology, and consequences of obesity and visceral adiposity in HIV …

Highly active antiretroviral therapy (HAART) regimens, especially those including protease
inhibitors have been shown to cause, in a high proportion of HIV-infected patients, a …

Introduction: Efficient antiretroviral-treatment (ART) generally allows control of HIV infection.
However, persons-living-with-HIV (PLWH), when aging, present a high prevalence of …

OBJECTIVE—Metabolic syndrome is a cluster of risk factors for cardiovascular disease and
type 2 diabetes. Definitions exist to identify those “at risk.” Treatment of HIV infection with …

HIV-infected patients on highly active antiretroviral therapy (HAART) have increased
prevalence of a number of chronic metabolic disorders of multifactorial but unclear etiology …

Abstract Changes in fat distribution, dyslipidemia, disordered glucose metabolism, and lactic
acidosis have emerged as significant challenges to the treatment of human …

Objectives With the use of potent antiretroviral therapy in patients with HIV disease, changes
in lipid parameters and glucose homeostasis have been noted. However, these effects have …